New [99mTc]bombesin analogues with improved biodistribution for targeting gastrin releasing-peptide receptor-positive tumors.
Elisa Garcı́a Garayoa(Paul Scherrer Institute), P. A. Schubiger(Paul Scherrer Institute), Peter Bläuenstein(Paul Scherrer Institute), Dirk Tourwé(Vrije Universiteit Brussel), Annette G. Beck‐Sickinger(Leipzig University of Applied Sciences), Christian Schweinsberg(Paul Scherrer Institute), Alain Blanc(Paul Scherrer Institute), Véronique Maes(Vrije Universiteit Brussel), Dominique Rüegg(Paul Scherrer Institute)
PubMed
March 1, 2007
Cited by 54
Related Papers
XVI. International Union of Pharmacology Recommendations for the Nomenclature of Neuropeptide Y, Peptide YY, and Pancreatic Polypeptide Receptors
|Pharmacological Reviews|1998|893
GPR39 Signaling Is Stimulated by Zinc Ions But Not by Obestatin
|Endocrinology|2006|432
Herbal drugs and phytopharmaceuticals
|Pharmaceutica Acta Helvetiae|1995|415
The Concise Guide to PHARMACOLOGY 2023/24: G protein-coupled receptors
|British Journal of Pharmacology|2023|390
The first highly potent and selective non-peptide neuropeptide Y Y1 receptor antagonist: BIBP3226
|European Journal of Pharmacology|1994|374